These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9384673)

  • 1. The role of cytokines in modulating neonatal myelopoiesis and host defense.
    Rosenthal J; Cairo MS
    Cytokines Mol Ther; 1995 Sep; 1(3):165-76. PubMed ID: 9384673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis.
    Parravicini E; van de Ven C; Anderson L; Cairo MS
    Transfus Med Rev; 2002 Jan; 16(1):11-24. PubMed ID: 11788926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil transfusions in the treatment of neonatal sepsis.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1989; 11(2):227-34. PubMed ID: 2665551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiology of granulocyte and macrophage colony-stimulating factors in host defense.
    Weisbart RH; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):401-9. PubMed ID: 2483721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of expression of immunoregulatory and cytokine genes and its association with the immaturity in neonatal phagocytic and cellular immunity.
    Satwani P; Morris E; van de Ven C; Cairo MS
    Biol Neonate; 2005; 88(3):214-27. PubMed ID: 16210844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates.
    Bracho F; Goldman S; Cairo MS
    Curr Opin Hematol; 1998 May; 5(3):215-20. PubMed ID: 9664163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of myeloid development and function by colony stimulating factors.
    Barreda DR; Hanington PC; Belosevic M
    Dev Comp Immunol; 2004 May; 28(5):509-54. PubMed ID: 15062647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease.
    van de Geijn GJ; Aarts LH; Erkeland SJ; Prasher JM; Touw IP
    Rev Physiol Biochem Pharmacol; 2003; 149():53-71. PubMed ID: 12687405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines.
    Kondo M; Scherer DC; Miyamoto T; King AG; Akashi K; Sugamura K; Weissman IL
    Nature; 2000 Sep; 407(6802):383-6. PubMed ID: 11014194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
    Möhle R; Kanz L
    Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Special Education.
    Kozutsumi H
    Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
    Fernández-Varón E; Villamayor L
    Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of myeloid colony-stimulating factors in neonates with septicemia.
    Bernstein HM; Calhoun DA; Christensen RD
    Curr Opin Pediatr; 2002 Feb; 14(1):91-4. PubMed ID: 11880741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics.
    Wood PA; Hrushesky WJ; Klevecz R
    Exp Hematol; 1998 Jun; 26(6):523-33. PubMed ID: 9620286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines: a new immunotherapy.
    Cairo MS
    Clin Perinatol; 1991 Jun; 18(2):343-59. PubMed ID: 1879112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis of cord blood neutrophils and their response to colony-stimulating factors.
    Uguz A; Coskun M; Yuzbey S; Kizilors A; Karadogan I; Gura A; Yoldas B; Oygur N; Yegin O
    Am J Perinatol; 2002 Nov; 19(8):427-34. PubMed ID: 12541215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of functionally distinct STAT5 proteins by IL-5 and GM-CSF during eosinophil and neutrophil differentiation from human CD34+ hematopoietic stem cells.
    Caldenhoven E; van Dijk TB; Tijmensen A; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
    Stem Cells; 1998; 16(6):397-403. PubMed ID: 9831865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.